Clinical Trial Update: Ceftidoren Versus Levofloxacin in the Treatment of Patients With Acute Exacerbations of Chronic Bronchitis (AECB) [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing ceftidoren versus levofloxacin for acute exacerbations of chronic bronchitis in COPD has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease
• Exacerbation of Chronic Bronchitis

Drugs mentioned

• Ceftidoren (ceftidoren)
• Levofloxacin (Levofloxacin)

Snippet

Sponsor: University of Milan | Conditions: COPD Exacerbation | Phase 4 | Status: COMPLETED